ID SCUB2_HUMAN Reviewed; 999 AA.
AC Q9NQ36; Q2NKQ8; Q6ZWI1;
DT 31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT 12-SEP-2018, sequence version 3.
DT 04-NOV-2026, entry version 179.
DE RecName: Full=Signal peptide, CUB and EGF-like domain-containing protein 2 {ECO:0000303|PubMed:19480626};
DE AltName: Full=Scube/You {ECO:0000250|UniProtKB:Q9JJS0};
DE Flags: Precursor;
GN Name=SCUBE2 {ECO:0000303|PubMed:12270931, ECO:0000312|HGNC:HGNC:30425};
GN Synonyms=CEGP1 {ECO:0000303|PubMed:11528127};
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX PubMed=11528127; DOI=10.1159/000056999;
RA Amid C., Bahr A., Mujica A., Sampson N., Bikar S.E., Winterpacht A.,
RA Zabel B., Hankeln T., Schmidt E.R.;
RT "Comparative genomic sequencing reveals a strikingly similar architecture
RT of a conserved syntenic region on human chromosome 11p15.3 (including gene
RT ST5) and mouse chromosome 7.";
RL Cytogenet. Cell Genet. 93:284-290(2001).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT MET-591.
RX PubMed=14702039; DOI=10.1038/ng1285;
RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA Isogai T., Sugano S.;
RT "Complete sequencing and characterization of 21,243 full-length human
RT cDNAs.";
RL Nat. Genet. 36:40-45(2004).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=16554811; DOI=10.1038/nature04632;
RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT "Human chromosome 11 DNA sequence and analysis including novel gene
RT identification.";
RL Nature 440:497-500(2006).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [5]
RP TISSUE SPECIFICITY.
RX PubMed=12270931; DOI=10.1074/jbc.m207410200;
RA Yang R.-B., Ng C.K.D., Wasserman S.M., Colman S.D., Shenoy S., Mehraban F.,
RA Koemueves L.G., Tomlinson J.E., Topper J.N.;
RT "Identification of a novel family of cell-surface proteins expressed in
RT human vascular endothelium.";
RL J. Biol. Chem. 277:46364-46373(2002).
RN [6]
RP SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH SHH AND PTCH1, FUNCTION,
RP AND GLYCOSYLATION.
RX PubMed=19480626; DOI=10.1042/bj20090341;
RA Tsai M.T., Cheng C.J., Lin Y.C., Chen C.C., Wu A.R., Wu M.T., Hsu C.C.,
RA Yang R.B.;
RT "Isolation and characterization of a secreted, cell-surface glycoprotein
RT SCUBE2 from humans.";
RL Biochem. J. 422:119-128(2009).
RN [7]
RP FUNCTION, INTERACTION WITH SHH, AND SUBUNIT.
RX PubMed=22902404; DOI=10.1016/j.celrep.2012.07.010;
RA Tukachinsky H., Kuzmickas R.P., Jao C.Y., Liu J., Salic A.;
RT "Dispatched and scube mediate the efficient secretion of the cholesterol-
RT modified hedgehog ligand.";
RL Cell Rep. 2:308-320(2012).
RN [8]
RP FUNCTION, INTERACTION WITH SHH, AND SUBUNIT.
RX PubMed=22677548; DOI=10.1101/gad.191866.112;
RA Creanga A., Glenn T.D., Mann R.K., Saunders A.M., Talbot W.S., Beachy P.A.;
RT "Scube/You activity mediates release of dually lipid-modified Hedgehog
RT signal in soluble form.";
RL Genes Dev. 26:1312-1325(2012).
RN [9]
RP INTERACTION WITH SHH, FUNCTION, SUBUNIT, AND DOMAIN.
RX PubMed=24522195; DOI=10.1242/jcs.137695;
RA Jakobs P., Exner S., Schuermann S., Pickhinke U., Bandari S., Ortmann C.,
RA Kupich S., Schulz P., Hansen U., Seidler D.G., Grobe K.;
RT "Scube2 enhances proteolytic Shh processing from the surface of Shh-
RT producing cells.";
RL J. Cell Sci. 127:1726-1737(2014).
RN [10]
RP REVIEW.
RX PubMed=26875496; DOI=10.1016/j.ydbio.2016.02.009;
RA Xavier G.M., Seppala M., Barrell W., Birjandi A.A., Geoghegan F.,
RA Cobourne M.T.;
RT "Hedgehog receptor function during craniofacial development.";
RL Dev. Biol. 415:198-215(2016).
RN [11]
RP FUNCTION, AND INTERACTION WITH VEGFR2.
RX PubMed=27834687; DOI=10.1161/atvbaha.116.308546;
RA Lin Y.C., Chao T.Y., Yeh C.T., Roffler S.R., Kannagi R., Yang R.B.;
RT "Endothelial SCUBE2 interacts with VEGFR2 and regulates VEGF-induced
RT angiogenesis.";
RL Arterioscler. Thromb. Vasc. Biol. 37:144-155(2017).
RN [12]
RP INTERACTION WITH SCUBE3.
RX PubMed=33308444; DOI=10.1016/j.ajhg.2020.11.015;
RG Genomics England Research Consortium;
RA Lin Y.C., Niceta M., Muto V., Vona B., Pagnamenta A.T., Maroofian R.,
RA Beetz C., van Duyvenvoorde H., Dentici M.L., Lauffer P., Vallian S.,
RA Ciolfi A., Pizzi S., Bauer P., Gruening N.M., Bellacchio E.,
RA Del Fattore A., Petrini S., Shaheen R., Tiosano D., Halloun R.,
RA Pode-Shakked B., Albayrak H.M., Isik E., Wit J.M., Dittrich M.,
RA Freire B.L., Bertola D.R., Jorge A.A.L., Barel O., Sabir A.H.,
RA Al Tenaiji A.M.J., Taji S.M., Al-Sannaa N., Al-Abdulwahed H., Digilio M.C.,
RA Irving M., Anikster Y., Bhavani G.S.L., Girisha K.M., Haaf T., Taylor J.C.,
RA Dallapiccola B., Alkuraya F.S., Yang R.B., Tartaglia M.;
RT "SCUBE3 loss-of-function causes a recognizable recessive developmental
RT disorder due to defective bone morphogenetic protein signaling.";
RL Am. J. Hum. Genet. 108:115-133(2021).
RN [13]
RP FUNCTION.
RX PubMed=35231446; DOI=10.1016/j.devcel.2022.02.008;
RA Huang P., Wierbowski B.M., Lian T., Chan C., Garcia-Linares S., Jiang J.,
RA Salic A.;
RT "Structural basis for catalyzed assembly of the Sonic hedgehog-Patched1
RT signaling complex.";
RL Dev. Cell 57:670-685(2022).
CC -!- FUNCTION: Lipid-binding protein carrier required for sonic hedgehog
CC (SHH) long-range signaling: binds to the dually lipid-modified Sonic
CC hedgehog protein N-product (ShhN) and promotes its release from
CC producing cells, allowing it to act as a morphogen for distant
CC signaling (PubMed:19480626, PubMed:22677548, PubMed:22902404,
CC PubMed:35231446). ShhN is then transferred to the CDON-BOC heterodimer
CC and GAS1 coreceptors to reach its target, the patched receptor (PTCH1
CC or PTCH2), followed by activation of the smoothened signaling pathway
CC (PubMed:35231446). May also enhance the proteolytic processing
CC (shedding) of the lipid-modified N- and C- terminal of ShhNp at the
CC cell surface (PubMed:24522195). Synergizes with DISP1 to increase SHH
CC secretion (PubMed:22902404). Probable cell surface coreceptor for
CC VEGFR2 involved in VEGFR2-mediated angiogenesis (PubMed:27834687).
CC {ECO:0000269|PubMed:19480626, ECO:0000269|PubMed:22677548,
CC ECO:0000269|PubMed:22902404, ECO:0000269|PubMed:24522195,
CC ECO:0000269|PubMed:27834687, ECO:0000269|PubMed:35231446}.
CC -!- SUBUNIT: Forms homooligomers (PubMed:19480626). Forms heterooligomers
CC with SCUBE1 (PubMed:19480626). Forms heterooligomers with SCUBE3
CC (PubMed:33308444). Interacts with SHH via the cholesterol anchor of the
CC dually lipid-modified SHH (ShhNp) (PubMed:19480626, PubMed:22677548,
CC PubMed:22902404). Interacts with PTCH1 (PubMed:19480626). Interacts
CC with VEGFR2 (PubMed:27834687). {ECO:0000269|PubMed:19480626,
CC ECO:0000269|PubMed:22677548, ECO:0000269|PubMed:22902404,
CC ECO:0000269|PubMed:27834687, ECO:0000269|PubMed:33308444}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19480626}. Cell
CC surface {ECO:0000269|PubMed:19480626}. Note=Secreted and tethered at
CC the cell surface. {ECO:0000269|PubMed:19480626}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=3;
CC Name=1;
CC IsoId=Q9NQ36-1; Sequence=Displayed;
CC Name=2;
CC IsoId=Q9NQ36-2; Sequence=VSP_021294, VSP_039955;
CC Name=3;
CC IsoId=Q9NQ36-3; Sequence=VSP_021293, VSP_021295;
CC -!- TISSUE SPECIFICITY: Expressed in a broad spectrum of adult tissues
CC (PubMed:12270931). {ECO:0000269|PubMed:12270931}.
CC -!- DOMAIN: The CUB domain is important for the interaction with the
CC cholesterol-anchor of SHH (PubMed:24522195). The CUB domain regulates
CC protease recruitment and activation during SHH shedding
CC (PubMed:24522195). {ECO:0000269|PubMed:24522195}.
CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19480626}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ400877; CAB92285.1; -; Genomic_DNA.
DR EMBL; AK123039; BAC85521.1; -; mRNA.
DR EMBL; AC079296; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; BC111690; AAI11691.1; -; mRNA.
DR CCDS; CCDS53599.1; -. [Q9NQ36-3]
DR CCDS; CCDS7797.2; -. [Q9NQ36-2]
DR CCDS; CCDS81553.1; -. [Q9NQ36-1]
DR RefSeq; NP_001164161.1; NM_001170690.3. [Q9NQ36-3]
DR RefSeq; NP_001317128.1; NM_001330199.3. [Q9NQ36-1]
DR RefSeq; NP_066025.2; NM_020974.4. [Q9NQ36-2]
DR AlphaFoldDB; Q9NQ36; -.
DR BioGRID; 121754; 2.
DR CORUM; Q9NQ36; -.
DR FunCoup; Q9NQ36; 149.
DR IntAct; Q9NQ36; 1.
DR NDEx; IQUERY-CP-SCUBE2; 2 NDEx IQuery Curated Pathways.
DR STRING; 9606.ENSP00000310658; -.
DR GlyConnect; Q9NQ36; 1 N-Linked glycan (1 site).
DR GlyCosmos; Q9NQ36; 3 sites, 1 glycan.
DR GlyGen; Q9NQ36; 5 sites, 1 N-linked glycan (1 site), 2 O-linked glycans (2 sites).
DR iPTMnet; Q9NQ36; -.
DR PhosphoSitePlus; Q9NQ36; -.
DR BioMuta; SCUBE2; -.
DR DMDM; 311033510; -.
DR jPOST; Q9NQ36; -.
DR MassIVE; Q9NQ36; -.
DR PaxDb; 9606-ENSP00000310658; -.
DR PeptideAtlas; Q9NQ36; -.
DR ProteomicsDB; 82071; -. [Q9NQ36-1]
DR ProteomicsDB; 82072; -. [Q9NQ36-2]
DR ProteomicsDB; 82073; -. [Q9NQ36-3]
DR Antibodypedia; 1601; 189 antibodies from 28 providers.
DR DNASU; 57758; -.
DR Ensembl; ENST00000309263.7; ENSP00000310658.3; ENSG00000175356.15. [Q9NQ36-1]
DR Ensembl; ENST00000450649.6; ENSP00000415187.2; ENSG00000175356.15. [Q9NQ36-3]
DR Ensembl; ENST00000520467.5; ENSP00000429969.1; ENSG00000175356.15. [Q9NQ36-2]
DR GeneID; 57758; -.
DR KEGG; hsa:57758; -.
DR UCSC; uc001mhj.3; human. [Q9NQ36-1]
DR AGR; HGNC:30425; -.
DR ClinPGx; PA134908812; -.
DR CTD; 57758; -.
DR DisGeNET; 57758; -.
DR GeneCards; SCUBE2; -.
DR HGNC; HGNC:30425; SCUBE2.
DR HPA; ENSG00000175356; Tissue enhanced (epididymis).
DR MalaCards; SCUBE2; -.
DR MIM; 611747; gene.
DR OpenTargets; ENSG00000175356; -.
DR VEuPathDB; HostDB:ENSG00000175356; -.
DR GeneTree; ENSGT00940000153185; -.
DR HOGENOM; CLU_013079_0_0_1; -.
DR InParanoid; Q9NQ36; -.
DR OrthoDB; 4062651at2759; -.
DR PAN-GO; Q9NQ36; 3 GO annotations based on evolutionary models.
DR PhylomeDB; Q9NQ36; -.
DR PathwayCommons; Q9NQ36; -.
DR Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR Agora; ENSG00000175356; -.
DR BioGRID-ORCS; 57758; 10 hits in 1148 CRISPR screens.
DR ChiTaRS; SCUBE2; human.
DR GenomeRNAi; 57758; -.
DR Pharos; Q9NQ36; Tbio.
DR PRO; PR:Q9NQ36; -.
DR Proteomes; UP000005640; Chromosome 11.
DR RNAct; Q9NQ36; protein.
DR Bgee; ENSG00000175356; Expressed in corpus epididymis and 133 other cell types or tissues.
DR ExpressionAtlas; Q9NQ36; baseline and differential.
DR GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR GO; GO:0140597; F:protein carrier activity; IDA:UniProtKB.
DR GO; GO:0030509; P:BMP signaling pathway; IBA:GO_Central.
DR GO; GO:0055001; P:muscle cell development; IBA:GO_Central.
DR GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB.
DR GO; GO:0007224; P:smoothened signaling pathway; IBA:GO_Central.
DR CDD; cd00041; CUB; 1.
DR CDD; cd00054; EGF_CA; 1.
DR FunFam; 2.10.25.10:FF:000032; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X1; 1.
DR FunFam; 2.10.50.10:FF:000002; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X1; 1.
DR FunFam; 2.10.25.10:FF:000199; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X2; 1.
DR FunFam; 2.10.25.10:FF:000237; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR FunFam; 2.10.25.10:FF:000256; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR FunFam; 2.10.50.10:FF:000028; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR FunFam; 2.10.50.10:FF:000029; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR FunFam; 2.10.25.10:FF:000028; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR FunFam; 2.10.25.10:FF:000030; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR FunFam; 2.10.25.10:FF:000035; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR FunFam; 2.10.25.10:FF:000037; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR FunFam; 2.60.120.290:FF:000002; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR FunFam; 2.10.25.10:FF:000008; Signal peptide, CUB domain, EGF-like 2; 1.
DR Gene3D; 2.10.25.10; Laminin; 9.
DR Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 1.
DR Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 3.
DR InterPro; IPR026823; cEGF.
DR InterPro; IPR000859; CUB_dom.
DR InterPro; IPR000742; EGF.
DR InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR InterPro; IPR018097; EGF_Ca-bd_CS.
DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR InterPro; IPR024731; NELL2-like_EGF.
DR InterPro; IPR049883; NOTCH1_EGF-like.
DR InterPro; IPR052071; SCUB_EGF-like_domain.
DR InterPro; IPR035914; Sperma_CUB_dom_sf.
DR InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR PANTHER; PTHR24046; SIGNAL PEPTIDE, CUB AND EGF-LIKE DOMAIN-CONTAINING; 1.
DR PANTHER; PTHR24046:SF3; SIGNAL PEPTIDE, CUB AND EGF-LIKE DOMAIN-CONTAINING PROTEIN 2; 1.
DR Pfam; PF12662; cEGF; 1.
DR Pfam; PF00431; CUB; 1.
DR Pfam; PF12947; EGF_3; 1.
DR Pfam; PF07645; EGF_CA; 1.
DR Pfam; PF07699; Ephrin_rec_like; 3.
DR Pfam; PF14670; FXa_inhibition; 4.
DR SMART; SM00042; CUB; 1.
DR SMART; SM00181; EGF; 10.
DR SMART; SM00179; EGF_CA; 8.
DR SMART; SM01411; Ephrin_rec_like; 3.
DR SUPFAM; SSF57196; EGF/Laminin; 1.
DR SUPFAM; SSF57184; Growth factor receptor domain; 4.
DR SUPFAM; SSF49854; Spermadhesin, CUB domain; 1.
DR PROSITE; PS00010; ASX_HYDROXYL; 6.
DR PROSITE; PS01180; CUB; 1.
DR PROSITE; PS01186; EGF_2; 8.
DR PROSITE; PS50026; EGF_3; 4.
DR PROSITE; PS01187; EGF_CA; 6.
PE 1: Evidence at protein level;
KW Alternative splicing; Calcium; Developmental protein; Disulfide bond;
KW EGF-like domain; Glycoprotein; Lipid-binding; Proteomics identification;
KW Reference proteome; Repeat; Secreted; Signal.
FT SIGNAL 1..31
FT /evidence="ECO:0000255"
FT CHAIN 32..999
FT /note="Signal peptide, CUB and EGF-like domain-containing
FT protein 2"
FT /id="PRO_0000255580"
FT DOMAIN 45..85
FT /note="EGF-like 1; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 86..127
FT /note="EGF-like 2; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 128..168
FT /note="EGF-like 3; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 177..213
FT /note="EGF-like 4"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 217..252
FT /note="EGF-like 5"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 286..321
FT /note="EGF-like 6"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 323..363
FT /note="EGF-like 7; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 364..402
FT /note="EGF-like 8; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 403..443
FT /note="EGF-like 9; calcium-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DOMAIN 809..921
FT /note="CUB"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT REGION 847..856
FT /note="Interaction with the cholesterol-anchor of SHH"
FT /evidence="ECO:0000250|UniProtKB:Q9JJS0"
FT CARBOHYD 659
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 49..62
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 56..71
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 73..84
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 90..102
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 98..111
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 113..126
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 368..378
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 374..387
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 389..401
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 407..418
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 414..427
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 429..442
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 809..835
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT DISULFID 862..883
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT VAR_SEQ 444..569
FT /note="Missing (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:15489334"
FT /id="VSP_021293"
FT VAR_SEQ 482
FT /note="S -> SGLQGAYSVTCGSSSPLRNKQQKSNDSAFG (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:14702039"
FT /id="VSP_021294"
FT VAR_SEQ 639..695
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:14702039"
FT /id="VSP_039955"
FT VAR_SEQ 806..872
FT /note="NRRCGGELGDFTGYIESPNYPGNYPANTECTWTINPPPKRRILIVVPEIFLP
FT IEDDCGDYLVMRKTS -> T (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:15489334"
FT /id="VSP_021295"
FT VARIANT 591
FT /note="T -> M (in dbSNP:rs3751055)"
FT /evidence="ECO:0000269|PubMed:14702039"
FT /id="VAR_028870"
FT VARIANT 712
FT /note="Q -> H (in dbSNP:rs7395988)"
FT /id="VAR_028871"
FT VARIANT 752
FT /note="V -> G (in dbSNP:rs12419343)"
FT /id="VAR_028872"
FT VARIANT 791
FT /note="T -> S (in dbSNP:rs3751057)"
FT /id="VAR_028873"
FT VARIANT 843
FT /note="P -> R (in dbSNP:rs3751059)"
FT /id="VAR_028874"
FT CONFLICT 916
FT /note="V -> G (in Ref. 2; BAC85521)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 999 AA; 109957 MW; 61334844A0053095 CRC64;
MGVAGRNRPG AAWAVLLLLL LLPPLLLLAG AVPPGRGRAA GPQEDVDECA QGLDDCHADA
LCQNTPTSYK CSCKPGYQGE GRQCEDIDEC GNELNGGCVH DCLNIPGNYR CTCFDGFMLA
HDGHNCLDVD ECLENNGGCQ HTCVNVMGSY ECCCKEGFFL SDNQHTCIHR SEEGLSCMNK
DHGCSHICKE APRGSVACEC RPGFELAKNQ RDCILTCNHG NGGCQHSCDD TADGPECSCH
PQYKMHTDGR SCLEREDTVL EVTESNTTSV VDGDKRVKRR LLMETCAVNN GGCDRTCKDT
STGVHCSCPV GFTLQLDGKT CKDIDECQTR NGGCDHFCKN IVGSFDCGCK KGFKLLTDEK
SCQDVDECSL DRTCDHSCIN HPGTFACACN RGYTLYGFTH CGDTNECSIN NGGCQQVCVN
TVGSYECQCH PGYKLHWNKK DCVEVKGLLP TSVSPRVSLH CGKSGGGDGC FLRCHSGIHL
SSDVTTIRTS VTFKLNEGKC SLKNAELFPE GLRPALPEKH SSVKESFRYV NLTCSSGKQV
PGAPGRPSTP KEMFITVEFE LETNQKEVTA SCDLSCIVKR TEKRLRKAIR TLRKAVHREQ
FHLQLSGMNL DVAKKPPRTS ERQAESCGVG QGHAENQCVS CRAGTYYDGA RERCILCPNG
TFQNEEGQMT CEPCPRPGNS GALKTPEAWN MSECGGLCQP GEYSADGFAP CQLCALGTFQ
PEAGRTSCFP CGGGLATKHQ GATSFQDCET RVQCSPGHFY NTTTHRCIRC PVGTYQPEFG
KNNCVSCPGN TTTDFDGSTN ITQCKNRRCG GELGDFTGYI ESPNYPGNYP ANTECTWTIN
PPPKRRILIV VPEIFLPIED DCGDYLVMRK TSSSNSVTTY ETCQTYERPI AFTSRSKKLW
IQFKSNEGNS ARGFQVPYVT YDEDYQELIE DIVRDGRLYA SENHQEILKD KKLIKALFDV
LAHPQNYFKY TAQESREMFP RSFIRLLRSK VSRFLRPYK
//